This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
T2 Biosystems (TTOO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
T2 Biosystems (TTOO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Options Traders Betting on a Big Move in T2 Biosystems (TTOO) Stock?
by Aditi Saraogi
Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately.
T2 Biosystems (TTOO) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
T2 Biosystems (TTOO) delivered earnings and revenue surprises of 0.00% and 12.13%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Will T2 Biosystems (TTOO) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
T2 Biosystems (TTOO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Moving Average Crossover Alert: T2 Biosystems (TTOO)
by Zacks Equity Research
T2 Biosystems (TTOO) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
T2 Biosystems (TTOO) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
T2 Biosystems (TTOO) delivered earnings and revenue surprises of 0.00% and 1.11%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
T2 Biosystems (TTOO) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
T2 Biosystems (TTOO) delivered earnings and revenue surprises of -16.67% and 0.08%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
T2 Biosystems (TTOO) Jumps: Stock Rises 8.7%
by Zacks Equity Research
T2 Biosystems (TTOO) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
T2 Biosystems (TTOO) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
T2 Biosystems (TTOO) delivered earnings and revenue surprises of 20.00% and 32.45%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Will T2 Biosystems (TTOO) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
T2 Biosystems (TTOO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is T2 Biosystems (TTOO) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (TTOO) Outperforming Other Medical Stocks This Year?
Is T2 Biosystems (TTOO) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (TTOO) Outperforming Other Medical Stocks This Year?
Is T2 Biosystems (TTOO) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (TTOO) Outperforming Other Medical Stocks This Year?
The Zacks Analyst Blog Highlights: TTOO, KMDA and CERS
by Zacks Equity Research
The Zacks Analyst Blog Highlights: TTOO, KMDA and CERS
3 Plasma Stocks to Win Big on FDA's Convalescent EUA
by Tirthankar Chakraborty
Convalescent plasma stocks moved northward following FDA's emergency plasma authorization for COVID-19 treatment. Here're three of them that should be on your watch list -
Is T2 Biosystems (TTOO) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (TTOO) Outperforming Other Medical Stocks This Year?
Do Options Traders Know Something About T2 Biosystems (TTOO) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately.
T2 Biosystems (TTOO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, T2 Biosystems (TTOO) closed at $1.66, marking a +1.84% move from the previous day.
T2 Biosystems (TTOO) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
T2 Biosystems' (TTOO) second-quarter results are likely to reflect growth in product revenues.
T2 Biosystems (TTOO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, T2 Biosystems (TTOO) closed at $1.62, marking a +0.62% move from the previous day.
T2 Biosystems (TTOO) Stock Moves -0.75%: What You Should Know
by Zacks Equity Research
In the latest trading session, T2 Biosystems (TTOO) closed at $1.33, marking a -0.75% move from the previous day.
Company News for Jul 2, 2020
by Zacks Equity Research
Companies in the news are: M, FDX, BYND, TTOO
Has T2 Biosystems (TTOO) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (TTOO) Outperforming Other Medical Stocks This Year?
Are Options Traders Betting on a Big Move in T2 Biosystems (TTOO) Stock?
by Zacks Equity Research
Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately.
Has T2 Biosystems (TTOO) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (TTOO) Outperforming Other Medical Stocks This Year?